<p>隨着美國股市在與中國的貿易緊張局勢中波動，主要指數出現顯著的周度損失，投資者越來越關注小型股，認為它們在更廣泛的市場波動中可能提供機會。在這種情況下，識別有前景的小型公司至關重要，因為這些常被忽視的 “寶石” 可能在經濟不確定性中提供獨特的增長前景和韌性。</p>
<h3>美國十大未被發現的基本面強勁的寶藏股</h3>
<table>
<thead>
<tr>
<th>名稱</th>
<th>債務股本比</th>
<th>收入增長</th>
<th>盈利增長</th>
<th>健康評級</th>
</tr>
</thead>
<tbody>
<tr>
<td>南密歇根銀行控股公司</td>
<td>117.38%</td>
<td>8.87%</td>
<td>4.89%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Senstar Technologies</td>
<td>NA</td>
<td>-18.50%</td>
<td>29.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Metalpha Technology Holding</td>
<td>NA</td>
<td>75.66%</td>
<td>28.60%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>First Northern Community Bancorp</td>
<td>NA</td>
<td>8.05%</td>
<td>12.27%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>FineMark Holdings</td>
<td>115.37%</td>
<td>2.22%</td>
<td>-28.34%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Valhi</td>
<td>44.30%</td>
<td>1.10%</td>
<td>-1.40%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>NameSilo Technologies</td>
<td>14.73%</td>
<td>14.50%</td>
<td>-1.32%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Pure Cycle</td>
<td>5.02%</td>
<td>4.35%</td>
<td>-2.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Linkhome Holdings</td>
<td>7.03%</td>
<td>215.05%</td>
<td>239.56%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Greenfire Resources</td>
<td>35.48%</td>
<td>-1.31%</td>
<td>-25.79%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們美國基本面強勁的未被發現的寶藏股篩選器中的 291 只股票的完整列表。</p>
<p>我們將從我們的篩選結果中選取一些進行分析。</p>
<h2>Power Solutions International (PSIX)</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Power Solutions International, Inc. 設計、工程、製造、營銷和銷售發動機及電力系統，全球市值約為 19.7 億美元。</p>
<p><strong>運營：</strong> PSIX 的收入主要來自其工程集成電力發電系統，金額為 5.9749 億美元。公司的財務表現受到其成本結構和市場動態的影響。</p>
<p>Power Solutions International (PSI) 在過去一年中實現了 147.5% 的令人矚目的盈利增長，超越了電氣行業的 7.5%。公司還在五年內將其債務股本比顯著降低，從 1259.1% 降至令人滿意的 72.1%，表明財務健康狀況改善。PSI 的市盈率為 17.8 倍，相較於美國市場的平均市盈率 18.5 倍，具有良好的價值。最近的戰略舉措包括與 HD Hyundai Infracore 簽署新協議，並通過修訂信貸協議將借款能力提高至 1.35 億美元，增強了財務靈活性和增長潛力。</p>
<ul>
<li>在我們的健康報告中更詳細地瞭解 Power Solutions International 的潛力。</li>
<li>通過查看我們的歷史報告瞭解 Power Solutions International 的業績記錄。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 10 月 PSIX 的債務股本比</p>
<h2>Puma Biotechnology (PBYI)</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Puma Biotechnology, Inc. 是一家生物製藥公司，開發和商業化產品以提升美國及國際的癌症護理，市值為 2.579 億美元。</p>
<p><strong>運營：</strong> Puma Biotechnology 從其癌症護理產品中獲得 2.3806 億美元的收入。公司的淨利潤率趨勢提供了其財務表現的洞察。</p>
<p>Puma Biotechnology 在癌症護理領域表現出色，過去一年盈利增長達到 455.6%，超越了同行。其交易價格低於估計公允價值的 76.2%，且在五年內將債務股本比從 412.7% 降至 42.8%，儘管面臨挑戰，但仍呈現出引人注目的投資案例。公司在 2025 年第二季度報告了 5200 萬美元的收入，並從去年的虧損中轉為 586 萬美元的淨收入，但由於成本上升和對 NERLYNX 銷售的依賴，未來盈利預計將平均下降 34.1%。</p>
<ul>
<li>Puma Biotechnology 對 NERLYNX 的依賴在入組和特許權使用費收入下降的情況下挑戰了其增長。點擊這裏探索 Puma Biotechnology 的戰略前景的完整敍述。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 10 月 PBYI 的債務股本比</p>
<h2>Idaho Strategic Resources (IDR)</h2>
<p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Idaho Strategic Resources, Inc. 是一家資源型公司，專注於在北愛達荷州探索、開發和提取黃金、白銀和基礎金屬礦產資源，市值為 6.3606 億美元。</p>
<p><strong>運營：</strong> 公司的收入為 3050 萬美元，來源於探索和開發黃金、白銀和基礎金屬礦產資源。</p>
<p>Idaho Strategic Resources 在過去一年中展現出 74% 的盈利增長，顯著超越了金屬和礦業行業。公司在五年內將債務股本比從 29.2% 降至 6.3%，表明財務管理強勁。最近的盈利報告顯示，第二季度淨收入為 277 萬美元，較去年增加了 216 萬美元。儘管股價波動，Idaho Strategic 仍保持盈利，擁有足夠的現金覆蓋債務，並已被納入 S&amp;P/TSX 全球礦業指數。</p>
<ul>
<li>點擊這裏通過我們的詳細分析健康報告發現 Idaho Strategic Resources 的細微差別。</li>
<li>查看我們的歷史業績報告，以獲取對 Idaho Strategic Resources 過去表現的洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 10 月 IDR 的債務股本比</p>
<h2>接下來該如何做？</h2>
<ul>
<li>在這裏瀏覽 291 只具有強大基本面的美國未被發現的優質股票的完整清單。</li>
<li>已經擁有這些公司？通過將您的投資組合與 Simply Wall St 連接，清晰化您的投資決策，您可以輕鬆監控所有股票的關鍵指標。</li>
<li>Simply Wall St 是一款為長期股票投資者設計的革命性應用程序，免費且覆蓋全球所有市場。</li>
</ul>
<h2>考慮其他策略？</h2>
<ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>用顯示強勁增長潛力的公司來充實您的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
<li>尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章性質一般。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

PSIX

<p>隨着美國股市面臨與中國的貿易緊張局勢，投資者正將目光轉向小型股以尋找潛在機會。值得注意的小型公司包括 Power Solutions International、Puma Biotechnology 和 Idaho Strategic Resources，這些公司都顯示出令人印象深刻的盈利增長和改善的財務健康狀況。Power Solutions International 的市值為 19.7 億美元，盈利增長達 147.5%。Puma Biotechnology 的估值為 2.579 億美元，盈利增長達到 455.6%。Idaho Strategic Resources 的市值為 6.3606 億美元，報告的盈利增長為 74%。在市場波動中，這些公司代表了有前景的投資機會</p>

<p>As the U.S. stock market navigates renewed trade tensions with China, resulting in significant weekly losses for major indices, investors are increasingly turning their attention to small-cap stocks as potential opportunities amidst broader market volatility. In this climate, identifying promising small-cap companies can be crucial, as these often-overlooked gems may offer unique growth prospects and resilience despite economic uncertainties.</p>
<div class="lb-trans"><p>隨着美國股市在與中國的貿易緊張局勢中波動，主要指數出現顯著的周度損失，投資者越來越關注小型股，認為它們在更廣泛的市場波動中可能提供機會。在這種情況下，識別有前景的小型公司至關重要，因為這些常被忽視的 “寶石” 可能在經濟不確定性中提供獨特的增長前景和韌性。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals In The United States</h3>
<div class="lb-trans"><h3>美國十大未被發現的基本面強勁的寶藏股</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Southern Michigan Bancorp</td>
<td>117.38%</td>
<td>8.87%</td>
<td>4.89%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Senstar Technologies</td>
<td>NA</td>
<td>-18.50%</td>
<td>29.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Metalpha Technology Holding</td>
<td>NA</td>
<td>75.66%</td>
<td>28.60%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>First Northern Community Bancorp</td>
<td>NA</td>
<td>8.05%</td>
<td>12.27%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>FineMark Holdings</td>
<td>115.37%</td>
<td>2.22%</td>
<td>-28.34%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Valhi</td>
<td>44.30%</td>
<td>1.10%</td>
<td>-1.40%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>NameSilo Technologies</td>
<td>14.73%</td>
<td>14.50%</td>
<td>-1.32%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Pure Cycle</td>
<td>5.02%</td>
<td>4.35%</td>
<td>-2.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Linkhome Holdings</td>
<td>7.03%</td>
<td>215.05%</td>
<td>239.56%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Greenfire Resources</td>
<td>35.48%</td>
<td>-1.31%</td>
<td>-25.79%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名稱</th>
<th>債務股本比</th>
<th>收入增長</th>
<th>盈利增長</th>
<th>健康評級</th>
</tr>
</thead>
<tbody>
<tr>
<td>南密歇根銀行控股公司</td>
<td>117.38%</td>
<td>8.87%</td>
<td>4.89%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Senstar Technologies</td>
<td>NA</td>
<td>-18.50%</td>
<td>29.50%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Metalpha Technology Holding</td>
<td>NA</td>
<td>75.66%</td>
<td>28.60%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>First Northern Community Bancorp</td>
<td>NA</td>
<td>8.05%</td>
<td>12.27%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>FineMark Holdings</td>
<td>115.37%</td>
<td>2.22%</td>
<td>-28.34%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Valhi</td>
<td>44.30%</td>
<td>1.10%</td>
<td>-1.40%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>NameSilo Technologies</td>
<td>14.73%</td>
<td>14.50%</td>
<td>-1.32%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Pure Cycle</td>
<td>5.02%</td>
<td>4.35%</td>
<td>-2.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Linkhome Holdings</td>
<td>7.03%</td>
<td>215.05%</td>
<td>239.56%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>Greenfire Resources</td>
<td>35.48%</td>
<td>-1.31%</td>
<td>-25.79%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 291 stocks from our US Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們美國基本面強勁的未被發現的寶藏股篩選器中的 291 只股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我們將從我們的篩選結果中選取一些進行分析。</p>
</div><h2>Power Solutions International (PSIX)</h2>
<div class="lb-trans"><h2>Power Solutions International (PSIX)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Power Solutions International, Inc. designs, engineers, manufactures, markets, and sells engines and power systems globally with a market cap of approximately $1.97 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Power Solutions International, Inc. 設計、工程、製造、營銷和銷售發動機及電力系統，全球市值約為 19.7 億美元。</p>
</div><p><strong>Operations:</strong> PSIX generates revenue primarily from its Engineered Integrated Electrical Power Generation Systems, amounting to $597.49 million. The company's financial performance is influenced by its cost structure and market dynamics.</p>
<div class="lb-trans"><p><strong>運營：</strong> PSIX 的收入主要來自其工程集成電力發電系統，金額為 5.9749 億美元。公司的財務表現受到其成本結構和市場動態的影響。</p>
</div><p>Power Solutions International (PSI) has been making waves with its impressive earnings growth of 147.5% over the past year, outpacing the Electrical industry's 7.5%. The company has also reduced its debt to equity ratio significantly from 1259.1% to a satisfactory 72.1% over five years, indicating improved financial health. Trading at a price-to-earnings ratio of 17.8x, PSI is considered good value compared to the US market's average of 18.5x. Recent strategic moves include a new agreement with HD Hyundai Infracore and an increase in borrowing capacity to $135 million through an amended credit agreement, enhancing financial flexibility and growth potential.</p>
<div class="lb-trans"><p>Power Solutions International (PSI) 在過去一年中實現了 147.5% 的令人矚目的盈利增長，超越了電氣行業的 7.5%。公司還在五年內將其債務股本比顯著降低，從 1259.1% 降至令人滿意的 72.1%，表明財務健康狀況改善。PSI 的市盈率為 17.8 倍，相較於美國市場的平均市盈率 18.5 倍，具有良好的價值。最近的戰略舉措包括與 HD Hyundai Infracore 簽署新協議，並通過修訂信貸協議將借款能力提高至 1.35 億美元，增強了財務靈活性和增長潛力。</p>
</div><ul>
<li>Take a closer look at Power Solutions International's potential here in our health report.</li>
<li>Understand Power Solutions International's track record by examining our Past report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的健康報告中更詳細地瞭解 Power Solutions International 的潛力。</li>
<li>通過查看我們的歷史報告瞭解 Power Solutions International 的業績記錄。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/cf697026-8e81-481e-8cc4-27b2122c8803/chart/debt-equity-history-analysis"/></p>
<p>PSIX Debt to Equity as at Oct 2025</p>
<div class="lb-trans"><p>截至 2025 年 10 月 PSIX 的債務股本比</p>
</div><h2>Puma Biotechnology (PBYI)</h2>
<div class="lb-trans"><h2>Puma Biotechnology (PBYI)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Puma Biotechnology, Inc. is a biopharmaceutical company that develops and commercializes products to enhance cancer care both in the United States and internationally, with a market cap of $257.90 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Puma Biotechnology, Inc. 是一家生物製藥公司，開發和商業化產品以提升美國及國際的癌症護理，市值為 2.579 億美元。</p>
</div><p><strong>Operations:</strong> Puma Biotechnology generates revenue of $238.06 million from its cancer care products. The company's net profit margin trends provide insights into its financial performance.</p>
<div class="lb-trans"><p><strong>運營：</strong> Puma Biotechnology 從其癌症護理產品中獲得 2.3806 億美元的收入。公司的淨利潤率趨勢提供了其財務表現的洞察。</p>
</div><p>Puma Biotechnology, a player in the cancer care sector, has shown impressive earnings growth of 455.6% over the past year, outpacing its industry peers. Trading at 76.2% below its estimated fair value and with a debt-to-equity ratio reduced from 412.7% to 42.8% in five years, it presents an intriguing investment case despite challenges ahead. The company reported US$52 million in Q2 revenue for 2025 and turned a net income of US$5.86 million from a loss last year, but faces future earnings decline forecasts averaging 34.1% annually due to rising costs and reliance on NERLYNX sales alone.</p>
<div class="lb-trans"><p>Puma Biotechnology 在癌症護理領域表現出色，過去一年盈利增長達到 455.6%，超越了同行。其交易價格低於估計公允價值的 76.2%，且在五年內將債務股本比從 412.7% 降至 42.8%，儘管面臨挑戰，但仍呈現出引人注目的投資案例。公司在 2025 年第二季度報告了 5200 萬美元的收入，並從去年的虧損中轉為 586 萬美元的淨收入，但由於成本上升和對 NERLYNX 銷售的依賴，未來盈利預計將平均下降 34.1%。</p>
</div><ul>
<li>Puma Biotechnology's reliance on NERLYNX amid declining enrollments and royalty revenues challenges growth. Click here to explore the full narrative on Puma Biotechnology's strategic outlook.</li>
</ul>
<div class="lb-trans"><ul>
<li>Puma Biotechnology 對 NERLYNX 的依賴在入組和特許權使用費收入下降的情況下挑戰了其增長。點擊這裏探索 Puma Biotechnology 的戰略前景的完整敍述。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis"/></p>
<p>PBYI Debt to Equity as at Oct 2025</p>
<div class="lb-trans"><p>截至 2025 年 10 月 PBYI 的債務股本比</p>
</div><h2>Idaho Strategic Resources (IDR)</h2>
<div class="lb-trans"><h2>Idaho Strategic Resources (IDR)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 價值評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Idaho Strategic Resources, Inc. is a resource-based company focused on the exploration, development, and extraction of gold, silver, and base metal mineral resources in North Idaho with a market cap of $636.06 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Idaho Strategic Resources, Inc. 是一家資源型公司，專注於在北愛達荷州探索、開發和提取黃金、白銀和基礎金屬礦產資源，市值為 6.3606 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue of $30.50 million is derived from exploring and developing gold, silver, and base metal mineral resources.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入為 3050 萬美元，來源於探索和開發黃金、白銀和基礎金屬礦產資源。</p>
</div><p>Idaho Strategic Resources has been making waves with its impressive financial performance, showcasing a 74% earnings growth over the past year, significantly outpacing the Metals and Mining industry. The company has managed to reduce its debt-to-equity ratio from 29.2% to 6.3% over five years, indicating strong financial management. Recent earnings reports reveal a net income of US$2.77 million for the second quarter, up from US$2.16 million the previous year. Despite a volatile share price, Idaho Strategic remains profitable, with sufficient cash to cover its debts, and has been added to the S&amp;P/TSX Global Mining Index.</p>
<div class="lb-trans"><p>Idaho Strategic Resources 在過去一年中展現出 74% 的盈利增長，顯著超越了金屬和礦業行業。公司在五年內將債務股本比從 29.2% 降至 6.3%，表明財務管理強勁。最近的盈利報告顯示，第二季度淨收入為 277 萬美元，較去年增加了 216 萬美元。儘管股價波動，Idaho Strategic 仍保持盈利，擁有足夠的現金覆蓋債務，並已被納入 S&amp;P/TSX 全球礦業指數。</p>
</div><ul>
<li>Click here to discover the nuances of Idaho Strategic Resources with our detailed analytical health report.</li>
<li>Review our historical performance report to gain insights into Idaho Strategic Resources''s past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏通過我們的詳細分析健康報告發現 Idaho Strategic Resources 的細微差別。</li>
<li>查看我們的歷史業績報告，以獲取對 Idaho Strategic Resources 過去表現的洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/bf45f5b5-f8f3-4b22-894d-945982cc083d/chart/debt-equity-history-analysis"/></p>
<p>IDR Debt to Equity as at Oct 2025</p>
<div class="lb-trans"><p>截至 2025 年 10 月 IDR 的債務股本比</p>
</div><h2>Where To Now?</h2>
<div class="lb-trans"><h2>接下來該如何做？</h2>
</div><ul>
<li>Navigate through the entire inventory of 291 US Undiscovered Gems With Strong Fundamentals here.</li>
<li>Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.</li>
<li>Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏瀏覽 291 只具有強大基本面的美國未被發現的優質股票的完整清單。</li>
<li>已經擁有這些公司？通過將您的投資組合與 Simply Wall St 連接，清晰化您的投資決策，您可以輕鬆監控所有股票的關鍵指標。</li>
<li>Simply Wall St 是一款為長期股票投資者設計的革命性應用程序，免費且覆蓋全球所有市場。</li>
</ul>
</div><h2>Contemplating Other Strategies?</h2>
<div class="lb-trans"><h2>考慮其他策略？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>用顯示強勁增長潛力的公司來充實您的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
<li>尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章性質一般。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

美國市場中的未被發現的寶石，介紹三隻有前景的小盤股